| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Prothena Corporation plc (NASDAQ: PRTA)
PRTA Technical Analysis
5
| As on 9th Jun 2023 PRTA STOCK Price closed @ 69.50 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 37.22 & Strong Buy for SHORT-TERM with Stoploss of 37.84 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PRTASTOCK Price
| Open | 69.95 | Change | Price | % |
| High | 70.60 | 1 Day | -0.45 | -0.64 |
| Low | 68.72 | 1 Week | 3.07 | 4.62 |
| Close | 69.50 | 1 Month | 17.17 | 32.81 |
| Volume | 281200 | 1 Year | 22.47 | 47.78 |
| 52 Week High 78.59 | 52 Week Low 22.73 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| PRTA Daily Charts |
PRTA Intraday Charts |
Whats New @ Bazaartrend |
PRTA Free Analysis |
|
|
PRTA Important Levels Intraday
| RESISTANCE | 73.12 |
| RESISTANCE | 71.96 |
| RESISTANCE | 71.24 |
| RESISTANCE | 70.52 |
| SUPPORT | 68.48 |
| SUPPORT | 67.76 |
| SUPPORT | 67.04 |
| SUPPORT | 65.88 |
PRTA Forecast May 2024
| 4th UP Forecast | 95.65 |
| 3rd UP Forecast | 87.26 |
| 2nd UP Forecast | 82.08 |
| 1st UP Forecast | 76.9 |
| 1st DOWN Forecast | 62.1 |
| 2nd DOWN Forecast | 56.92 |
| 3rd DOWN Forecast | 51.74 |
| 4th DOWN Forecast | 43.35 |
PRTA Weekly Forecast
| 4th UP Forecast | 80.87 |
| 3rd UP Forecast | 77.22 |
| 2nd UP Forecast | 74.97 |
| 1st UP Forecast | 72.72 |
| 1st DOWN Forecast | 66.28 |
| 2nd DOWN Forecast | 64.03 |
| 3rd DOWN Forecast | 61.78 |
| 4th DOWN Forecast | 58.13 |
PRTA Forecast2024
| 4th UP Forecast | 182.4 |
| 3rd UP Forecast | 146.19 |
| 2nd UP Forecast | 123.81 |
| 1st UP Forecast | 101.43 |
| 1st DOWN Forecast | 37.57 |
| 2nd DOWN Forecast | 15.19 |
| 3rd DOWN Forecast | -7.19 |
| 4th DOWN Forecast | -43.4 |
Prothena Corporation plc ( NASDAQ USA Symbol : PRTA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PRTA Business Profile
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing PRX002/RG7935 that is in Phase 2 clinical trial for treating Parkinson's disease and other related synucleinopathies; and PRX004, an antibody that is in Phase 1 clinical trial for the treatment of ATTR amyloidosis. Its discovery-stage programs include Tau for treating Alzheimer's disease, frontotemporal dementia, progressive supranuclear palsy, chronic traumatic encephalopathy, and other tauopathies; Aß, or Amyloid Beta, a protein for the treatment of Alzheimer's disease; TDP-43 for amyotrophic lateral sclerosis and frontotemporal dementia; and other products for neurodegenerative diseases. The company has a license, development, and commercialization agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. to develop and commercialize antibodies that target alpha-synuclein; and a collaboration agreement with Bristol-Myers Squibb to develop antibodies. Prothena Corporation plc was founded in 2012 and is based in Dublin, Ireland. Address: 77 Sir John Rogerson?s Quay, Dublin, Ireland, 2
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service